The most recent data suggest that between 22.9%4 and 25%5 of US adults between the ages of 18 and 65 (44 to 48 million individuals) meet the criteria for metabolic syndrome (Met S), with prevalence higher among females, and increasing significantly with age and body weight.
This study set out to ascertain the impact of a targeted, gene-based personalized wellness program on reducing employees’ future risk of metabolic syndrome.  The study showed statistically significant trends in improved clinical outcomes and a large reduction in average health care costs per participant.

 


Gregory Steinberg, MB, BCh, Adam Scott, MBA, Joseph Honcz, MBA, Claire Spettell, PhD, and Susil Pradhan, MS
American College of Occupational and Environmental Medicine